NCT02512458View on ClinicalTrials.gov

Study of the Effect of Chemotherapy With Cabazitaxel on Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 29, 2015

Primary Completion Date

December 31, 2019

Study Completion Date

December 27, 2019

Conditions
Bone Metastatic Prostate Cancer
Interventions
DRUG

Cabazitaxel

Trial Locations (6)

11528

"General Hospital of Athens Alexandra, Unit of Medical Oncology, Dept of Clinical Therapeutics", Athens

14564

Agii Anargiri Cancer Hospital, 3rd Dept of Medical Oncology, Athens

15125

Athens Medical Center, Dept of Medical Oncology, Athens

45110

Ioannina University Hospital, Dept of Medical Oncology, Ioannina

54645

EUROMEDICA General Clinic of Thessaloniki, Thessaloniki

56429

Papageorgiou General Hospital, Dept of Medical Oncology, Thessaloniki

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Hellenic Cooperative Oncology Group

OTHER